India to Philippines: Montelukast Export Trade Route

The India to Philippines Montelukast corridor is one of India's established pharmaceutical export routes, with 309 shipments documented worth a combined $13.3M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's montelukast manufacturing sector.

Across 45 active suppliers, the average shipment value stands at $43.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with montelukast's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 25.3%, placing it at rank #6 among India's top montelukast export destinations globally.

On the import side, key buyers of Indian montelukast in Philippines include The Cathay Drug Co Inc, AJANTA PHARMA PHILIPPINES INC, The Cathay Drug Co. Inc and 58 others. The Cathay Drug Co Inc is the single largest importer with 3 shipments valued at $2.6M USD.

India's montelukast exports to Philippines are driven primarily by a handful of large-scale manufacturers. AJANTA PHARMA LIMITED with 34 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 45 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AJANTA PHARMA LIMITED, AJANTA PHARMA LIMITED , BAFNA PHARMACEUTICALS LIMITED — together account for 76% of total trade value on this route. The average shipment value of $43.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as zykast tab 10/5mg[252000pac x 3 x 10 = 7560000][montelukast 10 mg plus levocetirizine 5 mg tablets]cont:as per invoice and zykast tab 10/5mg[187104 x 3 x 10 = 5613120][montelukast 10 mg plus levocetirizine 5 mg tablets]cont:as per invoice, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, The Cathay Drug Co Inc is the largest importer with 3 shipments worth $2.6M USD — representing 19% of all montelukast imports from India on this route. A total of 61 buyers are active on this corridor.